Richard Channick, MD
Critical Care Medicine · Boston, MANPI 1144255886
Payments from drug & device makers
Across 818 payments — averaging $786.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$320K
- Merck$134K
- Actelion Pharmaceuticals, Ltd$88K
- Bayer$59K
- Penumbra, Inc.$32K
- United Therapeutics Corporation$8K
- plus $3K from 11 others
Across 4 payments — averaging $1753.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$7K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 377 | $320,020 |
| Merck | 152 | $134,209 |
| Actelion Pharmaceuticals, Ltd | 45 | $88,058 |
| Bayer | 97 | $58,697 |
| Penumbra, Inc. | 29 | $31,642 |
| United Therapeutics Corporation | 66 | $8,066 |
| Inari Medical, Inc. | 8 | $992 |
| Johnson & Johnson(2 entities) | 7 | $386 |
| Liquidia Technologies, Inc. | 6 | $302 |
| Sandoz | 22 | $255 |
| Inquis Medical, Inc. | 3 | $249 |
| Imperative Care, Inc | 1 | $195 |
| Stryker | 1 | $136 |
| Boston Scientific | 1 | $88 |
| E.r. Squibb & Sons, L.L.C. | 1 | $81 |
| Gilead | 1 | $32 |
| Scpharmaceuticals Inc. | 1 | $20 |
How this compares
$643,427 in reported general payments places this provider in the 95th percentile of 158 critical care medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Boston
- Benjamin MedoffBoston$1.3M
- Akiva LeibowitzBoston$249K
- Hovig ChitilianBoston$68K
- Jerome CrowleyBoston$38K
- Michael DonninoBoston$25K
- Haval ChweichBoston$23K
- Diana Espinoza BarreraBoston$17K
- Catherine FioreBoston$13K
- Ilana KrummBoston$13K
- John ReichBoston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.